Evidence map›Paper›PMID 37875612›Full record

ReviewEuropean journal of clinical nutrition2024

Nutraceuticals and biotics in pediatric gastrointestinal disorders.

Antonio Corsello, Lorenzo Scatigno, Giulia Fiore, Stefano Baresi, Francesca Eletti, Gianvincenzo Zuccotti, Caterina Strisciuglio, Dario Dilillo, Elvira Verduci

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Antonio Corsello *Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.ORCID 0000-0003-4578-0066
Lorenzo Scatigno *Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
Giulia FioreDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
Stefano BaresiDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.ORCID 0009-0005-2460-2756
Francesca ElettiDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
Gianvincenzo ZuccottiDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.ORCID 0000-0002-2795-9874
Caterina StrisciuglioDepartment of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy. caterina.strisciuglio@unicampania.it.
Dario DililloDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
Elvira VerduciDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
University of Milan · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years there has been growing interest in the use of nutraceuticals and biotics in both pediatric and adult clinical practice. The overlapping and often ambiguous symptoms of both functional and organic gastrointestinal disorders have led to a search for alternative therapeutic approaches that avoid the use of synthetic or chemical treatments. However, while nutraceuticals and natural supplements are widely used, their health benefits are often not supported by adequate scientific evidence, and an unregulated use of nutraceuticals can be potentially harmful. The correct use of nutraceuticals, prebiotics, and probiotics can optimize the results of drug therapy in some cases and reduce the risk of side effects. This review aims to provide clinicians with guidance on the use of complementary therapies for pediatric gastrointestinal symptoms and disorders, highlighting the scarcity of studies on the kinetics and dynamics of nutraceuticals and biotics. While it is generally difficult to associate their intakes with adverse events due to the often-coexisting pharmacological treatments, it is essential to avoid the abandonment of traditional drugs with proven efficacy in the treatment of single diseases. Overall, the use of nutraceuticals, prebiotics, and probiotics in pediatric gastroenterological practice requires caution and medical supervision. Further research is needed to determine the effects of alternative therapies on pediatric gastrointestinal symptoms and disorders, and to ensure their safe and effective use in the clinical practice.

Indexed as

Complementary TherapiesGastrointestinal DiseasesProbioticsChildDietary SupplementsHumansPrebioticsPrebiotics

Identifiers

PMID37875612
OpenAlexW4387904388

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.